2024-11-25 05:52:39
Innovent Announces NMPA Granted New Indication Approval for SULINNO® (Adalimumab Injection) in China for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
Corporate/ 2023-07-23
Innovent Announces NMPA Granted New Indi...

SAN FRANCISCOand SUZHOU,China,Nov. 23,2020-- Innovent Biologics,Inc. (Innovent) (HKEX: 01801),a world-class biopharmaceutical company that d...

3SBio Inc. received milestone payment of USD 4 million upon commencement of phase III clinical program of SEL-212
Corporate/ 2023-07-23
3SBio Inc. received milestone payment of...

SHENYANG,China,Nov. 23,2020-- Chinese leading biopharmaceutical company,3SBio Inc.(01530.HK,the "Company"),announced today that Se...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release